Jim Simons Exelixis, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Exelixis, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 15,101,716 shares of EXEL stock, worth $316 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
15,101,716
Previous 15,615,716
3.29%
Holding current value
$316 Million
Previous $375 Million
4.34%
% of portfolio
0.56%
Previous 0.58%
Shares
22 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
246MCall Options Held
1.7MPut Options Held
1.02M-
Black Rock Inc. New York, NY34.9MShares$729 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$644 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA26.7MShares$558 Million2.94% of portfolio
-
State Street Corp Boston, MA13.1MShares$274 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.32MShares$111 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $6.73B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...